IDT Australia Limited (ASX:IDT)

Market Cap	27.87M
Revenue (ttm)	19.77M
Net Income (ttm)	-8.06M
Shares Out	428.82M
EPS (ttm)	-0.02
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	446,741
Average Volume	152,293
Open	0.0650
Previous Close	0.0650
Day's Range	0.0650 - 0.0650
52-Week Range	0.0550 - 0.1300
Beta	1.01
RSI	34.90
Earnings Date	Aug 26, 2025

About IDT Australia

IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API) and finished dose forms (FDF) products in Australia, Asia, Europe, and the Unites States. and internationally. The company offers microbiological and analytical testing, clinical packaging, and pharmacy services. It also provides medicinal cannabis and psychedelics; oral finished doses; and aseptic fill and finish solutions for liquid and lyophilised forms. In addition, it offers mRNA and ADCs. Further, the company provid...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1975
• Employees: 100
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: IDT

Financial Performance

In 2025, IDT Australia's revenue was 19.77 million, an increase of 40.99% compared to the previous year's 14.02 million. Losses were -8.06 million, 49.0% more than in 2024.